Response to propranolol in infantile hemangioma

Pediatr Int. 2016 Jul;58(7):662-5. doi: 10.1111/ped.12992.

Abstract

Propranolol, 2 mg/kg/day, is effective in the treatment of infantile hemangioma. We report the response to propranolol in infants with hemangioma at a dose of 1 mg/kg/day. Sixteen infants with newly diagnosed infantile hemangioma were given propranolol at a dose titrated from 0.5 mg/kg/day then increased to 1 or 2 mg/kg/day based on response to treatment until the lesions showed clinical stability for 3 consecutive months. Five out of 16 patients (31.2%) responded to propranolol at 1 mg/kg/day, while the remainder required 2 mg/kg/day for response. Vascular endothelial growth factor significantly decreased after treatment (median, 117.8 pg/mL; range, 35.3-468.7 pg/mL vs 59.2 pg/mL; range, 26.3-133.0 pg/mL; P = 0.016). Therefore, we recommend initiating treatment at 0.5 mg/kg/day for 2 days, then 1 mg/kg/day for 1 month. If the hemangioma has not decreased in size by 1 month follow up, the dose is subsequently increased to 2 mg/kg/day.

Keywords: hemangioma; infant; propranolol; vascular endothelial growth factor.

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Biopsy
  • Dose-Response Relationship, Drug
  • Female
  • Hemangioma / diagnosis
  • Hemangioma / drug therapy*
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Male
  • Propranolol / administration & dosage*
  • Skin / pathology
  • Skin Neoplasms
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Propranolol